Literature DB >> 16132681

A comparative proteomic analysis of the rat brain during rebound hyperphagia induced by space-restriction.

Keiichi Ishihara1, Kyoko Nakata, Nobuyuki Yamagishi, Shinichi Iwasaki, Nobuo Kiriike, Takumi Hatayama.   

Abstract

Although neurochemical changes have been reported in the brain in animal models of binge eating, biochemical changes of specific proteins in the brain are unknown. Our aim was to elucidate brain proteins altered in rats during enhanced rebound hyperphargia. Rats were deprived of food for 22 h/day for 6 days, then allowed free access to food for 24 h in normal cages (rebound hyperphargia) or in space-restricted cages (enhanced rebound hyperphargia). Proteins extracted from the rat brain were separated by two-dimensional gel electrophoresis, and compared with those from control rats freely fed for 7 days in normal cages. Proteins expressed differently from controls were identified by N-terminal amino acid sequencing and mass fingerprinting using a MALDI-TOF mass spectrometer. Among proteins in the corpus striatum, frontal lobe, hippocampus and thalamus/hypothalamus, ubiquitin C-terminal hydrolase L1 and peroxiredoxin 2 decreased in the hippocampus and phosphatidylethanolamine-binding protein increased in the thalamus/hypothalamus of rats with the enhanced rebound hyperphargia induced by space-restriction. In this study, we first demonstrated that three brain proteins changed in rats during enhanced rebound hyperphagia. These proteins might have pathophysiologic relevance to binge eating. (Mol Cell Biochem 276: 21-29, 2005).

Entities:  

Mesh:

Year:  2005        PMID: 16132681     DOI: 10.1007/s11010-005-2465-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

1.  Prefrontal and striatal dopamine metabolism during enhanced rebound hyperphagia induced by space restriction--a rat model of binge eating.

Authors:  K Inoue; N Kiriike; M Okuno; Y Fujisaki; M Kurioka; S Iwasaki; S Yamagami
Journal:  Biol Psychiatry       Date:  1998-12-15       Impact factor: 13.382

Review 2.  From dietary restraint to binge eating: some theoretical considerations.

Authors:  R J Tuschl
Journal:  Appetite       Date:  1990-04       Impact factor: 3.868

Review 3.  Dietary restraint: a theoretical and empirical review.

Authors:  A J Ruderman
Journal:  Psychol Bull       Date:  1986-03       Impact factor: 17.737

4.  Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice.

Authors:  K Saigoh; Y L Wang; J G Suh; T Yamanishi; Y Sakai; H Kiyosawa; T Harada; N Ichihara; S Wakana; T Kikuchi; K Wada
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

Review 5.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

6.  The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors.

Authors:  U Hengst; H Albrecht; D Hess; D Monard
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

7.  Thioredoxin-dependent peroxide reductase from yeast.

Authors:  H Z Chae; S J Chung; S G Rhee
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

8.  The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression.

Authors:  G M Goodwin; C G Fairburn; P J Cowen
Journal:  Arch Gen Psychiatry       Date:  1987-11

9.  Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes.

Authors:  D C Jimerson; M D Lesem; W H Kaye; T D Brewerton
Journal:  Arch Gen Psychiatry       Date:  1992-02

Review 10.  Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.

Authors:  W H Kaye; T E Weltzin
Journal:  J Clin Psychiatry       Date:  1991-12       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.